Measurement standards in cancer are typically developed through collaborative efforts involving multiple stakeholders, including:
Oncologists and medical professionals Researchers and scientists Regulatory bodies such as the FDA or EMA Professional organizations like the American Society of Clinical Oncology (ASCO) Patient advocacy groups
These groups work together to review current evidence, conduct trials, and reach a consensus on the most effective and reliable measurement methods.
